Terumo Vietnam and Daiichi Sankyo Vietnam to advance cardiovascular care

This partnership highlights both companies’ commitment to improving healthcare by equipping cardiologists with cutting-edge knowledge and skills in interventional cardiology.

The MoU is part of a broader effort by both companies to contribute to the sustainable development of Vietnam’s healthcare system. Photo: Daiichi Sankyo Vietnam

Vietnam faces a rising burden of cardiovascular disease, requiring healthcare professionals to stay updated with the latest knowledge and techniques in diagnosis and intervention. Recognising this urgent need, Terumo Vietnam and Daiichi Sankyo will explore key joint initiatives under this MoU.

Accordingly, they will deliver up-to-date knowledge and innovative techniques through scientific symposia, hands-on workshops, and continuous medical education sessions both onsite and online.

They will also help major comprehensive interventional cardiovascular centres in Vietnam in improving multidisciplinary team workflows, and fostering exchange and collaboration between international and local medical centres.

“We are proud to join hands with Daiichi Sankyo Vietnam in this significant effort to strengthen the capabilities of interventional cardiologists across the country,” said Gaurav Chhillar, general director of Terumo Vietnam Medical Equipment. “By investing in education and skills development, we aim to contribute meaningfully to society through healthcare in Vietnam.”

Both Terumo Vietnam and Daiichi Sankyo are renowned for their contributions to medical innovation. While Terumo Vietnam brings decades of expertise in medical devices, Daiichi Sankyo contributes advanced antiplatelet therapies. Together, both companies aim to improve outcomes for acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI) by enhancing knowledge, techniques, and experience through expert collaboration with local medical associations, and supporting interventional cardiology centres to strengthen multidisciplinary workflows between departments (ER, ICU, outpatient) to improve post-PCI care.

Photo: Daiichi Sankyo Vietnam

“This partnership represents a shared commitment to healthcare excellence,” said Yukinori Tominaga, general director of Daiichi Sankyo Vietnam. “We believe that by working closely with healthcare providers, we can help enhance clinical decision-making and improve treatment outcomes for cardiovascular patients.”

The MoU is part of a broader effort by both companies to contribute to the sustainable development of Vietnam’s healthcare system. By focusing on education, mentorship, and knowledge dissemination, this collaboration aims to build a foundation for continuous professional growth in the medical community.

Terumo is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for more than 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since.

Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion, and cell therapy technology, to medical products essential for daily clinical practice, such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. Operating in more than 20 countries, it draws upon over a century of scientific expertise and a robust pipeline of promising new medicines. With a team of 15,000 employees worldwide, Daiichi Sankyo is committed to developing innovative therapies and improving patient care.

Stakeholders help improve adolescent reproductive health services in Yen Bai Save the Children and Daiichi Sankyo in collaboration with the Department of Health, Pediatric and Obstetrics Hospital of Yen Bai province, on July 4 organised a project launching workshop, aiming to protect maternal and child health.

Vietnam Heart Association, Novartis Vietnam partner to promote cardiovascular education Following a successful first phase in 2020, Novartis Vietnam and the Vietnam Heart Association (VNHA) have officially signed a collaboration agreement on implementing the second phase of the Tam Diem virtual talk show series on cardiology for healthcare professionals (HCPs) nationwide.

Stakeholders seek to improve cardiovascular-renal-metabolic care in Vietnam On May 15, more than 150 healthcare experts in both Hanoi and Ho Chi Minh City – including representatives from departments and agencies of the Ministry of Health, associations, doctors, and leading specialists in clinical research – gathered at a conference to discuss cardiovascular-renal-metabolic (CVRM) care.